Comparison of once-daily versus twice-daily dosing of valsartan in patients with chronic stable heart failure

BACKGROUND: The safety of once-daily (qd) dosing of valsartan in heart failure (HF) patients is not known. HYPOTHESIS: This 10-week, double-blind trial examined the relative safety and efficacy of valsartan administered qd versus twice-daily (bid). METHODS: HF patients (NYHA class II–III) receiving...

Descripción completa

Detalles Bibliográficos
Autores principales: Anand, Inder S, Deswal, Anita, Kereiakes, Dean J, Purkayastha, Das, Zappe, Dion H
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2922305/
https://www.ncbi.nlm.nih.gov/pubmed/20730060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2922305/
https://www.ncbi.nlm.nih.gov/pubmed/20730060

Ejemplares similares